Vitamin D Homeostasis in Sarcoidosis
Who is this study for? Adult patients with Sarcoidosis
What treatments are being studied? Vitamin D2
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Healthy Volunteers: f
View:
• Stable medical condition defined as no hospitalization or emergency room visit in the previous 3 months
• No evidence of active pulmonary or systemic infection
• No other active inflammatory disease,
• No active malignancy.
• Normal serum ionized calcium level
Locations
United States
Texas
University of Texas Southwestern Medical Center, and Parkland Health and Hospital System
RECRUITING
Dallas
Contact Information
Primary
Connie Hsia, MD
Connie.Hsia@utsouthwestern.edu
2146483426
Backup
Khashayar Sakhaee, MD
Khashayar.Sakhaee@utsouthwestern.edu
2146480324
Time Frame
Start Date: 2010-07-01
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 90
Treatments
Experimental: Low vit-D, Ergocalciferol
Low serum vitamin D level, split by use or non-use of systemic corticosteroid. Vitamin D2 (Ergocalciferol) 50,000 units will be given by mouth once a week for 12 weeks, then once a month for 12 weeks.~Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Placebo_comparator: Low vit-D, Placebo
Low serum vitamin D level, split by use or non-use of systemic corticosteroid. Placebo capsules of identical size and appearance will be given by mouth once a week for 12 weeks, then once a month for 12 weeks.~Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Other: Normal vit-D, control
Normal serum vitamin D level, split by use or non-use of systemic corticosteroid.~Daily dietary requirement (calcium citrate with vitamin D2 (200 mg/250 Units tablets, 4 tablets per day) will be given by mouth for 24 weeks).
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center